GPX4 and breast carcinoma: Selective inhibition of GPX4-mediated glutathione synthesis and FSP-mediated coenzyme Q10 reduction using nano-catalytic particles was successfully used to induce pronounced ferroptotic cell death in chemotherapy-resistant breast cancer cells and animal models [248].